Seladelpar improves PBC transplant-free survival – EASL 2022 – POSTER
Seladelpar treatment of patients with primary cholangitis (PBC) for 2 years improves the GLOBE PBC score and predicts improved transplant-free survival Seladelpar treatment over 2 years resulted in a sustainedOCA improves event free survival – EASL 2022 – POSTER
Long-term obeticholic acid (OCA) for primary biliary cholangitis (PBC) in a clinical trial improved event free survival (death, liver transplant and hepatic decompensation) compared to external controls from the GLOBALPBC itch & Health Related Quality of Life -EASL 2022 – POSTER
More than just an itch: Impact of cholestatic pruritus in primary biliary cholangitis (PBC) on health-related quality of life (HRQoL) Cholestatic pruritus (particularly severe pruritus) has a significant negative impactPBC prevalence on the rise – EASL 2022 – POSTER
The prevalence of primary biliary cholangitis (PBC) is on the rise: a Canadian population-based study In this well-defined cohort, we reported a significant increase in the prevalence of PBC inExercise improves fatigue in PBC patients – EASL 2022- POSTER
Home-based exercise in patients with refractory fatigue associated primary biliary cholangitis: final results from the EXerCise Intervention in cholesTatic LivEr Disease (EXCITED) clinical trial A 12-wk individualized HBEP, incorporating resistance12 Week mind-body intervention for PBC patients – EASL 2022 – POSTER
A randomized control trial evaluating the impact of a web-based mind-body wellness intervention for patients with primary biliary cholangitis This 12-week intervention improved measures of mental wellness and quality of life.
Sarka’s PBC Blog #3 – July 4 , 2022
Meet Barbie! I’ve always had pets. Cats and dogs. They have been part of my life for as long as I can remember. Some of them I chose. Some were Sarka’s PBC Blog #2
You can’t go on this journey alone, and that means communicating all of this with your friends and family. I found this step hard. I was still in disbelief and